U.S. Stock Market Update: 5 Key Things to Know Before Trading Starts Today

U.S. stock futures are moving lower after a turbulent week. Concerns over economic uncertainty, corporate earnings, and major acquisitions are shaping the market outlook. Here are five major developments to watch before the opening bell.

1. Stock Futures Decline After a Bumpy Trading Week

U.S. stock futures are in the red as market volatility continues. The S&P 500, Nasdaq, and Dow Jones Industrial Average are all down more than 1% in premarket trading. Investors are closely watching economic data and policy updates, with concerns about a potential economic slowdown still lingering. Meanwhile, bond yields have dipped, with the 10-year Treasury yield hovering around 4.25%. Oil prices are climbing, while gold futures are showing minor losses.

2. Trump Talks Trade Policies, Doesn't Rule Out Economic Slowdown

In a weekend interview, former President Donald Trump defended his tariff policies, stating that they are meant to strengthen the U.S. economy in the long run. However, he acknowledged that the economic impact might take time, and he did not dismiss the possibility of a short-term slowdown. His comments have fueled further uncertainty, adding to investor concerns about economic stability.

3. Oracle Faces Market Pressure Ahead of Earnings Report

Shares of cloud computing giant Oracle (ORCL) are down 1.5% in premarket trading ahead of its highly anticipated earnings report later today. Analysts expect the company to post an 8% revenue increase, reaching $14.38 billion, with adjusted earnings per share (EPS) projected at $1.49. Investors are also looking for updates on Oracle’s multi-billion-dollar AI initiative, Stargate, which could play a key role in its future growth.

4. Redfin Shares Surge After $1.75 Billion Buyout by Rocket Companies

Redfin (RDFN) stock is soaring 75% in early trading after mortgage lender Rocket Companies (RKT) announced a $1.75 billion all-stock acquisition deal. Rocket aims to enhance the home-buying experience by integrating Redfin’s real estate services with its mortgage platform. Despite the positive response for Redfin, Rocket’s stock has dropped 11% as investors evaluate the financial impact of the deal.

5. Novo Nordisk Drops After Disappointing Weight-Loss Drug Trial

Shares of pharmaceutical giant Novo Nordisk (NVO) are down 7% following the latest trial results for its weight-loss drug, CagriSema. The Phase 3 study showed that patients with type 2 diabetes experienced an average weight loss of 15.7% over 68 weeks—falling short of the company’s 25% target. The results have raised concerns about the drug’s market potential, especially as competition in the weight-loss medication sector intensifies.

What Investors Should Watch Today

With stock futures down and economic uncertainty lingering, investors will be closely monitoring corporate earnings, inflation data, and Federal Reserve signals for further direction. Volatility is expected to continue, making today’s trading session one to watch closely.

Also Read: Tesla Stock Drops 45% – Analyst Says It’s a ‘Gut Check Moment